Terms: = Liver cancer AND VHL, HRCA1, P40337, 7428, ENSG00000134086, RCA1, VHL1 AND Treatment
25 results:
1. UBE2S promotes malignant properties via vhl/HIF-1α and vhl/JAK2/STAT3 signaling pathways and decreases sensitivity to sorafenib in hepatocellular carcinoma.
Wu J; Xu X; Wu S; Shi W; Zhang G; Cao Y; Wang Z; Wu J; Jiang C
Cancer Med; 2023 Sep; 12(17):18078-18097. PubMed ID: 37563971
[TBL] [Abstract] [Full Text] [Related]
2. Crosstalk Between Metabolism and Immune Activity Reveals Four Subtypes With Therapeutic Implications in Clear Cell Renal Cell Carcinoma.
Wang Y; Zheng XD; Zhu GQ; Li N; Zhou CW; Yang C; Zeng MS
Front Immunol; 2022; 13():861328. PubMed ID: 35479084
[TBL] [Abstract] [Full Text] [Related]
3. Histone chaperone FACT complex coordinates with HIF to mediate an expeditious transcription program to adapt to poorly oxygenated cancers.
Shen J; Yang C; Zhang MS; Chin DW; Chan FF; Law CT; Wang G; Cheng CL; Chen M; Wan RT; Wu M; Kuang Z; Sharma R; Lee TKW; Ng IO; Wong CC; Wong CM
Cell Rep; 2022 Feb; 38(5):110304. PubMed ID: 35108543
[TBL] [Abstract] [Full Text] [Related]
4. Clinical presentation, genotype-phenotype correlations, and outcome of pancreatic neuroendocrine tumors in Von Hippel-Lindau syndrome.
Penitenti F; Landoni L; Scardoni M; Piredda ML; Cingarlini S; Scarpa A; D'Onofrio M; Girelli D; Davi MV
Endocrine; 2021 Oct; 74(1):180-187. PubMed ID: 34036514
[TBL] [Abstract] [Full Text] [Related]
5. Efficacy and the Adverse Effects of Oral Versus Intravenous Arsenic for Acute Promyelocytic Leukemia: A Meta-Analysis of Randomized-Controlled Studies.
Sasijareonrat N; Jahn N; Ungprasert P; Owattanapanich W
Technol Cancer Res Treat; 2020; 19():1533033820937008. PubMed ID: 32583728
[TBL] [Abstract] [Full Text] [Related]
6. Third-line sunitinib treatment in a
Li X; Gao L; Zhang L; Sun H; Gou H
Cancer Biol Ther; 2020 Sep; 21(9):785-789. PubMed ID: 32552305
[TBL] [Abstract] [Full Text] [Related]
7. Correlation Between von Hippel-Lindau Gene Expression and Tumor SUVmax and Survival Prognosis in Hepatocellular Carcinoma.
Li G; Shen Y; Wang F; Hong S; Cai M
Med Sci Monit; 2020 Feb; 26():e920473. PubMed ID: 32075951
[TBL] [Abstract] [Full Text] [Related]
8. Adipose-derived exosomes deliver miR-23a/b to regulate tumor growth in hepatocellular cancer by targeting the vhl/HIF axis.
Liu Y; Tan J; Ou S; Chen J; Chen L
J Physiol Biochem; 2019 Aug; 75(3):391-401. PubMed ID: 31321740
[TBL] [Abstract] [Full Text] [Related]
9. COX-2/PGE2 Axis Regulates HIF2α Activity to Promote Hepatocellular Carcinoma Hypoxic Response and Reduce the Sensitivity of Sorafenib treatment.
Dong XF; Liu TQ; Zhi XT; Zou J; Zhong JT; Li T; Mo XL; Zhou W; Guo WW; Liu X; Chen YY; Li MY; Zhong XG; Han YM; Wang ZH; Dong ZR
Clin Cancer Res; 2018 Jul; 24(13):3204-3216. PubMed ID: 29514844
[No Abstract] [Full Text] [Related]
10. An Advanced Well-differentiated Pancreatic Neuroendocrine Carcinoma (NET-G3) Associated with Von Hippel-Lindau Disease.
Miki M; Kawabe K; Igarashi H; Abe T; Ohishi Y; Hashimoto R; Karashima T; Yamasaki I; Inoue K; Ito T; Ogawa Y
Intern Med; 2018 Jul; 57(14):2007-2011. PubMed ID: 29491307
[TBL] [Abstract] [Full Text] [Related]
11. Exceptional Response to Temsirolimus in a Metastatic Clear Cell Renal Cell Carcinoma With an Early Novel
Rodríguez-Moreno JF; Apellaniz-Ruiz M; Roldan-Romero JM; Durán I; Beltrán L; Montero-Conde C; Cascón A; Robledo M; García-Donas J; Rodríguez-Antona C
J Natl Compr Canc Netw; 2017 Nov; 15(11):1310-1315. PubMed ID: 29118224
[TBL] [Abstract] [Full Text] [Related]
12. Evaluation and management of pancreatic lesions in patients with von Hippel-Lindau disease.
Keutgen XM; Hammel P; Choyke PL; Libutti SK; Jonasch E; Kebebew E
Nat Rev Clin Oncol; 2016 Sep; 13(9):537-49. PubMed ID: 27030075
[TBL] [Abstract] [Full Text] [Related]
13. Analysis of DNA methylation and gene expression in radiation-resistant head and neck tumors.
Chen X; Liu L; Mims J; Punska EC; Williams KE; Zhao W; Arcaro KF; Tsang AW; Zhou X; Furdui CM
Epigenetics; 2015; 10(6):545-61. PubMed ID: 25961636
[TBL] [Abstract] [Full Text] [Related]
14. Pazopanib for the treatment of renal cell carcinoma.
Welsh SJ; Fife K
Future Oncol; 2015; 11(8):1169-79. PubMed ID: 25832874
[TBL] [Abstract] [Full Text] [Related]
15. The role of inflammation in kidney cancer.
de Vivar Chevez AR; Finke J; Bukowski R
Adv Exp Med Biol; 2014; 816():197-234. PubMed ID: 24818725
[TBL] [Abstract] [Full Text] [Related]
16. Heterogeneous drug target expression as possible basis for different clinical and radiological response to the treatment of primary and metastatic renal cell carcinoma: suggestions from bench to bedside.
Santoni M; Santini D; Massari F; Conti A; Iacovelli R; Burattini L; Tortora G; Falconi M; Montironi R; Cascinu S
Cancer Metastasis Rev; 2014 Mar; 33(1):321-31. PubMed ID: 24337954
[TBL] [Abstract] [Full Text] [Related]
17. Genotype and tumor locus determine expression profile of pseudohypoxic pheochromocytomas and paragangliomas.
Shankavaram U; Fliedner SM; Elkahloun AG; Barb JJ; Munson PJ; Huynh TT; Matro JC; Turkova H; Linehan WM; Timmers HJ; Tischler AS; Powers JF; de Krijger R; Baysal BE; Takacova M; Pastorekova S; Gius D; Lehnert H; Camphausen K; Pacak K
Neoplasia; 2013 Apr; 15(4):435-47. PubMed ID: 23555188
[TBL] [Abstract] [Full Text] [Related]
18. Hypoxia-mediated sorafenib resistance can be overcome by EF24 through Von Hippel-Lindau tumor suppressor-dependent HIF-1α inhibition in hepatocellular carcinoma.
Liang Y; Zheng T; Song R; Wang J; Yin D; Wang L; Liu H; Tian L; Fang X; Meng X; Jiang H; Liu J; Liu L
Hepatology; 2013 May; 57(5):1847-57. PubMed ID: 23299930
[TBL] [Abstract] [Full Text] [Related]
19. A case of von Hippel-Lindau disease with juxtapapillary retinal capillary hemangioma and nutcracker phenomenon.
Yavaş GF; Okur N; Küsbeci T; Norman E; Inan Ü
Int Ophthalmol; 2013 Jun; 33(3):309-14. PubMed ID: 23114531
[TBL] [Abstract] [Full Text] [Related]
20. Enzastaurin inhibits invasion and metastasis in lung cancer by diverse molecules.
Körner A; Mudduluru G; Manegold C; Allgayer H
Br J Cancer; 2010 Sep; 103(6):802-11. PubMed ID: 20736951
[TBL] [Abstract] [Full Text] [Related]
[Next]
